Atomo Diagnostics (ASX:AT1) said it secured a AU$450,000 order from the National Association of People with HIV Australia for HIV self-tests, according to a Tuesday filing with the Australian bourse.
The revenue from this order is material, the filing said.
Shares of the company fell 6% in recent Tuesday trade, earlier hitting an all-time low.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.